Mirvaso Gel (Brimonidine 0.33%)

Mirvaso is the new FDA approved treatment from Galderma that was previously known as Sansrosa, CD07805/47 and Col-118. Mirvaso is the only topical treatment officially approved for the relief of the red face of rosacea. Mirvaso is Brimonidine Topical Gel 0.33% and is available in 30g and 45g tubes, on prescription only. It is used once per day and can last as long as 12 hours.

See below for Mirvaso User Reviews, news and updates

Recent Rosacea Blog Posts

Mirvaso Gel Pump – for those who don’t like a tube?

Following in the footsteps of making Metrogel 1% available in a pump, Galderma has announced that Mirvaso Gel is now available in a pump dispenser. Previously Galderma has claimed the benefits of a pump over a tube include –  better looking dispenser, minimizing waste, easier compliance with prescribing instructions and “facilitating product handling”. Galderma Press […]

Continue Reading

Mirvaso works for Lupus, Dermatomyositis and Pityriasis Rubra Pilaris

The off label use for Mirvaso gel is becoming better documented with the publication of a recent paper suggesting that Mirvaso was well tolerated by and offered good benefits to sufferers of Systemic Lupus, Dermatomyositis and Pityriasis Rubra Pilaris. These conditions share a symptom – erythema, that is the appearance of a red face. Only 3 patients […]

Continue Reading

Mirvaso as indicator of sun damage redness

A novel clinical use for Mirvaso has been proposed by an article in the Australasian Journal of Dermatology. Researchers are suggesting that Mirvaso can been used to differentiate between the redness associated with rosacea and the redness of sun damaged skin. If the redness improves after application of Mirvaso then sun damage can be eliminated […]

Continue Reading

What a “sponsored” post looks like

Bloggers sometimes write sponsored posts about a topic that they may or may not be interested in. If you have never seen what a sponsored post might look like, I have linked to one below. This post highlights Mirvaso and Soolantra, seeking to promote these products through the voice of a blogger and user of […]

Continue Reading

Mirvaso and Soolantra together like best buddies

Galderma is proposing a Stage 4 trial of 188 participants to demonstrate the effectiveness of Mirvaso and Soolantra used together in treating the redness and papules and pustules of rosacea. The trial is looking for rosacea sufferers with between 15 and 70 papules and pustules and also a score of 3 or 4 in the Clinician’s […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.